Please use this identifier to cite or link to this item:
Title: One-year continuous inhaled nitric oxide for primary pulmonary hypertension
Authors: Pérez-Peñate, Gregorio 
Juliá-Serdá, Gabriel
Pulido-Duque, Juan María
Górriz-Gómez, Elias
Cabrera-Navarro, Pedro 
UNESCO Clasification: 32 Ciencias médicas
320508 Enfermedades pulmonares
Keywords: Pulmonary hypertension
Nitric oxide
Vasodilator agents
Issue Date: 2001
Journal: Chest (American College of Chest Physicians) 
Abstract: We describe a case of long-term administration of nitric oxide (NO) in a 32-year-old man who was admitted with exertional dyspnea and anasarca. A diagnosis of primary pulmonary hypertension was made. An acute vasodilator trial with inhaled NO showed a 5% reduction of the mean pulmonary artery pressure. Long-term NO inhalation therapy was initiated. Twenty days later, the dyspnea improved, the anasarca resolved, and the PaO(2) level increased. After 12 months of NO therapy, the patient remained stable and no signs of toxicity or tachyphylaxis were observed. To our knowledge, this is the first report of 1 year of continuously inhaled NO in an adult patient with primary pulmonary hypertension. These findings suggest that prolonged NO therapy might be an effective alternative, at a lower cost, to the continuous IV infusion of epoprostenol.
ISSN: 0012-3692
DOI: 10.1378/chest.119.3.970
Source: Chest[ISSN 0012-3692],v. 119(3), p. 970-973 (Marzo 2001)
Appears in Collections:Artículos
Show full item record


checked on May 28, 2023

Page view(s)

checked on Jan 7, 2023

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.